Increased risk of parkinsonism in women who underwent oophorectomy before menopause

Objective: There is increasing laboratory evidence for a neuroprotective effect of estrogen on the nigrostriatal pathway; however, the epidemiologic evidence remains limited and conflicting. We studied the association of oophorectomy performed before the onset of menopause with the risk of subsequent parkinsonism. Methods: We included all women who underwent either unilateral or bilateral oophorectomy before the onset of menopause for a noncancer indication from 1950 through 1987 while residing in Olmsted County, MN. Each member of the oophorectomy cohort was matched by age to a referent woman in the same population who had not undergone oophorectomy. In total, we studied 1,252 women with unilateral oophorectomy, 1,075 women with bilateral oophorectomy, and 2,368 referent women. Women were followed through death or end of study using a combination of direct or proxy interviews, neurologic examinations, medical records in a records-linkage system, and death certificates. Results: Women who underwent either unilateral or bilateral oophorectomy before the onset of menopause had an increased risk of parkinsonism compared with referent women (HR 1.68; 95% CI 1.06 to 2.67; p = 0.03), and the risk increased with younger age at oophorectomy (test for linear trend; p = 0.01). The findings were similar regardless of the indication for the oophorectomy, and for unilateral or bilateral oophorectomy considered separately. The findings were also consistent for Parkinson disease alone, but did not reach significance. Conclusions: Both unilateral and bilateral oophorectomy performed prior to menopause may be associated with an increased risk of parkinsonism and the effect may be age-dependent. However, our findings await independent replication.

[1]  L. Melton,et al.  Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause , 2007, Neurology.

[2]  M. Broder,et al.  Ovarian Conservation at the Time of Hysterectomy for Benign Disease , 2005, Obstetrics and gynecology.

[3]  M. Broder,et al.  Elective oophorectomy for benign gynecological disorders , 2007, Menopause.

[4]  Tom Siegfried,et al.  Neuroscience: It's all in the timing , 2007, Nature.

[5]  Mariza de Andrade,et al.  Survival patterns after oophorectomy in premenopausal women: a population-based cohort study. , 2006, The Lancet. Oncology.

[6]  S. Khosla,et al.  Androgen therapy in women: an Endocrine Society Clinical Practice guideline. , 2006, The Journal of clinical endocrinology and metabolism.

[7]  V. Henderson The Neurology of Menopause , 2006, The neurologist.

[8]  C. Tanner,et al.  Effect of reproductive factors and postmenopausal hormone use on the risk of Parkinson disease , 2005, Neurology.

[9]  C. Farquhar,et al.  The association of hysterectomy and menopause: a prospective cohort study , 2005, BJOG : an international journal of obstetrics and gynaecology.

[10]  D. Schaid,et al.  The Mayo Clinic Family Study of Parkinson’s Disease: Study Design, Instruments, and Sample Characteristics , 2005, Neuroepidemiology.

[11]  D. Dexter,et al.  Sex dimorphisms in the neuroprotective effects of estrogen in an animal model of Parkinson's disease , 2004, Pharmacology Biochemistry and Behavior.

[12]  P. Aridon,et al.  Risk of Parkinson disease in women , 2004, Neurology.

[13]  G. Wooten,et al.  Postmenopausal estrogen use affects risk for Parkinson disease. , 2004, Archives of neurology.

[14]  D. Dluzen,et al.  Acute effects of estrogen upon methamphetamine induced neurotoxicity of the nigrostriatal dopaminergic system , 2003, Journal of Neural Transmission.

[15]  F. Speizer,et al.  Caffeine, postmenopausal estrogen, and risk of Parkinson’s disease , 2003, Neurology.

[16]  D. Dexter,et al.  Differences in dopaminergic neuroprotective effects of estrogen during estrous cycle , 2003, Neuroreport.

[17]  Eun-Hee Ahn,et al.  Effect of hysterectomy on conserved ovarian function. , 2001, Yonsei medical journal.

[18]  D. Schaid,et al.  Hysterectomy, menopause, and estrogen use preceding Parkinson's disease: An exploratory case‐control study , 2001, Movement disorders : official journal of the Movement Disorder Society.

[19]  D. Dluzen,et al.  Tamoxifen abolishes estrogen's neuroprotective effect upon methamphetamine neurotoxicity of the nigrostriatal dopaminergic system , 2001, Neuroscience.

[20]  R. Roth,et al.  Estrogen Is Essential for Maintaining Nigrostriatal Dopamine Neurons in Primates: Implications for Parkinson's Disease and Memory , 2000, The Journal of Neuroscience.

[21]  T. Di Paolo,et al.  Stereospecific prevention by 17β‐estradiol of MPTP‐induced dopamine depletion in mice , 2000, Synapse.

[22]  A. Gade,et al.  Idiopathic selective amnesia with slow onset: A descriptive spect study , 2000, Neurobiology of Aging.

[23]  R. Gibbs Long-term treatment with estrogen and progesterone enhances acquisition of a spatial memory task by ovariectomized aged rats☆ , 2000, Neurobiology of Aging.

[24]  G. Cooper,et al.  FSH levels in relation to hysterectomy and to unilateral oophorectomy. , 1999, Obstetrics and gynecology.

[25]  A. Hofman,et al.  Estrogen receptor polymorphism predicts the onset of natural and surgical menopause. , 1999, The Journal of clinical endocrinology and metabolism.

[26]  D. Maraganore,et al.  Incidence and distribution of parkinsonism in Olmsted County, Minnesota, 1976–1990 , 1999, Neurology.

[27]  S. Fahn,et al.  The effect of estrogen replacement on early Parkinson’s disease , 1999, Neurology.

[28]  T. Spector,et al.  Genes control the cessation of a woman's reproductive life: a twin study of hysterectomy and age at menopause. , 1998, The Journal of clinical endocrinology and metabolism.

[29]  D. Schaid,et al.  Validation of a telephone questionnaire for Parkinson's disease. , 1998, Journal of clinical epidemiology.

[30]  J. O'Callaghan,et al.  The Impact of Gender and Estrogen on Striatal Dopaminergic Neurotoxicity , 1998, Annals of the New York Academy of Sciences.

[31]  K. Marder,et al.  Postmenopausal estrogen use and Parkinson's disease with and without dementia , 1998, Neurology.

[32]  D. Dluzen Estrogen decreases corpus striatal neurotoxicity in response to 6-hydroxydopamine , 1997, Brain Research.

[33]  S. Dean Hysterectomy and bone mineral density. , 1997, British journal of hospital medicine.

[34]  L. Melton,et al.  History of the Rochester Epidemiology Project. , 1996, Mayo Clinic proceedings.

[35]  I. Bukovsky,et al.  Ovarian function following abdominal hysterectomy with and without unilateral oophorectomy. , 1995, European journal of obstetrics, gynecology, and reproductive biology.

[36]  W. O'Fallon,et al.  Bilateral oophorectomy trends in Olmsted County, Minnesota, 1950-1987. , 1991, Epidemiology.